Hyderabad's strong IT and pharmaceutical sectors handle both valuable intellectual property and regulated health data, making rigorous, regular security testing a compliance necessity rather than an option.
Hyderabad's pharma and biotech clusters shift our focus toward research-data access controls and third-party integration risk more than a typical engagement elsewhere.
Research data, formulations, and clinical trial information represent high-value intellectual property that competitors and attackers alike target.
Patient and research data protection is both an ethical obligation and, increasingly, a regulatory one.
Large delivery centers managing client infrastructure need to demonstrate security maturity to the enterprises they serve.
Hyderabad's growing product ecosystem shares the same cloud and API security priorities as other major Indian tech hubs.
Pharma, IT services, or product — Hyderabad clients all get the same remote-delivered depth of testing, no matter the sector.
Complete Vulnerability Assessment and Penetration Testing engagements. Learn more →
Real-world exploitation testing to prove actual security impact. Learn more →
OWASP Top 10 and beyond — websites, admin panels, payment flows. Learn more →
Internal and external network infrastructure assessment. Learn more →
Systematic scanning and prioritized findings across your systems. Learn more →
Our firm is based in Uttarakhand and we've served Hyderabad clients — HITEC City, Gachibowli, Madhapur — entirely remotely since day one. If an on-site kickoff would help, that's something we can arrange for local teams.
Yes — we've structured engagements around research and formulation data protection for Hyderabad-based pharma and biotech clients, focusing on access control, data exposure, and third-party integration security, which are common risk areas in this sector.
Pricing begins at ₹12,000 + GST for a one-time assessment, unchanged by location. Your final quote depends on scope: how many systems, APIs, or applications need testing. We confirm the exact number after a short scoping conversation.
The final deliverable is a single, comprehensive report — an executive summary, every finding rated by severity, proof-of-concept evidence, and practical remediation steps for your dev and IT teams.
Yes, as long as we have written authorization from the system owner, which is standard on every project we run. An NDA and authorization letter are signed before testing starts, in line with the IT Act, 2000.
Write to us with a rough picture of your systems and we'll reply with a scope and fixed quote within 24–48 hours — no commitment needed.
Email Us for a Free Quote Or write to us at nexoryn.vapt@gmail.com